These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 20865683)

  • 21. Rare complications of diphenhydramine toxicity.
    Ramachandran K; Sirop P
    Conn Med; 2008 Feb; 72(2):79-82. PubMed ID: 18306834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
    Elbey MA; Cil H; Onturk E; Islamoglu Y
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long QT syndrome caused by noncardiac drugs.
    Viskin S; Justo D; Halkin A; Zeltser D
    Prog Cardiovasc Dis; 2003; 45(5):415-27. PubMed ID: 12704598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al.
    Perciaccante A; Fiorentini A
    Int J Cardiol; 2007 Nov; 122(3):255; author reply 256-7. PubMed ID: 17368589
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
    J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.
    Yamagiwa T; Amino M; Morita S; Yamamoto R; Saito T; Inokuchi S
    Clin Toxicol (Phila); 2010 Feb; 48(2):149-52. PubMed ID: 20199131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe tricyclic antidepressants poisoning--a case study].
    Zapalska-Pozarowska K; Szponar J; Tchórz M; Kostek H; Pozarowski W
    Przegl Lek; 2012; 69(8):621-3. PubMed ID: 23243947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
    Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF
    Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine.
    Luzza F; Raffa S; Saporito F; Oreto G
    Int J Clin Pract; 2006 May; 60(5):606-8. PubMed ID: 16700864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced long QT and torsade de pointes: recent advances.
    Kannankeril PJ; Roden DM
    Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined use of astemizole and ketoconazole resulting in torsade de pointes.
    Tsai WC; Tsai LM; Chen JH
    J Formos Med Assoc; 1997 Feb; 96(2):144-6. PubMed ID: 9071844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The QT interval and torsade de pointes.
    Moss AJ
    Drug Saf; 1999; 21 Suppl 1():5-10; discussion 81-7. PubMed ID: 10597863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terlipressin-induced ventricular arrhythmia.
    Urge J; Sincl F; Procházka V; Urbánek K
    Scand J Gastroenterol; 2008; 43(9):1145-8. PubMed ID: 18609153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Side effects, unwanted drug interactions and the problem of cardiotoxicity].
    Woroń J; Trabka-Janik E; Kostka-Trabka E
    Przegl Lek; 2003; 60(4):196-8. PubMed ID: 14569882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis.
    Link MS; Foote CB; Sloan SB; Homoud MK; Wang PJ; Estes NA
    Chest; 1997 Aug; 112(2):556-7. PubMed ID: 9266902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.